Selective inhibition of autoimmune exacerbation while preserving the anti-tumor clinical benefit using IL-6 blockade in a patient with advanced melanoma and Crohn’s disease: a case...

by Marc Uemura, Van A. Trinh, Cara Haymaker, Natalie Jackson, Dae Won Kim, James P. Allison, Padmanee Sharma, Luis Vence, Chantale Bernatchez, Patrick Hwu, Adi Diab
Published 2016-09-01

Depressive symptoms and cortisol rhythmicity predict survival in patients with renal cell carcinoma: role of inflammatory signaling.

by Lorenzo Cohen, Steven W Cole, Anil K Sood, Sarah Prinsloo, Clemens Kirschbaum, Jesusa M G Arevalo, Nicholas B Jennings, Shellie Scott, Luis Vence, Qi Wei, Diane Kentor, Laszlo Radvanyi, Nizar Tannir, Eric Jonasch, Pheroze Tamboli, Louis Pisters
Published 2012-01-01

Phase I clinical trial of combination imatinib and ipilimumab in patients with advanced malignancies

by Matthew J. Reilley, Ann Bailey, Vivek Subbiah, Filip Janku, Aung Naing, Gerald Falchook, Daniel Karp, Sarina Piha-Paul, Apostolia Tsimberidou, Siqing Fu, JoAnn Lim, Stacie Bean, Allison Bass, Sandra Montez, Luis Vence, Padmanee Sharma, James Allison, Funda Meric-Bernstam, David S. Hong
Published 2017-04-01